Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference44 articles.
1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008
2. Biomarkers and multiple drug resistance in breast cancer;O'Driscoll;Current Cancer Drug Targets,2006
3. Molecular mechanisms of drug resistance;Longley;J Pathol,2005
4. Overview of resistance to systemic therapy in patients with breast cancer;Gonzalez-Angulo;Adv Exp Med Biol,2007
5. Resistance to chemotherapy: new treatments and novel insights into an old problem;Raguz;Br J Cancer,2008
Cited by 298 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Restoration of miR-200c sensitizes breast cancer cells to cytarabine;2023-12-20
2. Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene;Breast Cancer Research and Treatment;2023-12-07
3. Alginate-based hydrogel platform embedding silver nanoparticles and cisplatin: characterization of the synergistic effect on a breast cancer cell line;Frontiers in Molecular Biosciences;2023-10-23
4. In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer;Biomedicines;2023-10-05
5. Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis;Frontiers in Endocrinology;2023-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3